کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3940415 1253587 2007 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection
چکیده انگلیسی

ObjectiveTo compare directly in vitro developmental competence between parthenogenetically activated and intracytoplasmic sperm injection (ICSI)-fertilized oocytes.DesignFor each patient, three metaphase II oocytes were randomized to the ICSI procedure, while n−3 were allocated to parthenogenetic activation.SettingUniversity hospital infertility unit.PatientsThirty-eight patients, aged 35.2 ± 3.3 years (mean ± SD) selected for ICSI.InterventionsAfter 1 hour from denudation, oocytes were either fertilized by ICSI (n = 114) or chemically activated (n = 104). Fertilized and activated oocytes were cultured for up to 3 and 5 days, respectively.Main Outcome MeasuresDevelopment rate, cell number, and morphological grade during culture.ResultsThe two groups showed no significant differences between rates of fertilization and parthenogenetic activation, development, and blastomere number on days 2 and 3 of culture. However, parthenotes showed a lower morphological grade, and a significantly lower proportion went on cleaving to day 3, when only activated rather than total numbers of oocytes were considered. On day 5 after activation, nine oocytes (8.6%) reached the blastocyst stage, representing 12.9% of parthenotes.ConclusionsSince most parameters examined in this study were similar between activated and fertilized oocytes, parthenogenetic activation may be a useful tool for the preclinical evaluation of experimental procedures.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Fertility and Sterility - Volume 87, Issue 1, January 2007, Pages 77–82
نویسندگان
, , , , , ,